Annual advances of traditional medicine on tumor immunity regulation in 2020
Journal Title: Traditional Medicine Research - Year 2021, Vol 6, Issue 3
Abstract
Tumor burden remains a global health problem that threatens human life worldwide. Over the past few years, the evolution of immune checkpoint inhibitors has represented one of the most successful approaches in the field of tumor therapy. Drugs regulating tumor immune microenvironment or enhancing body immunity have indicated a novel perspective to treat tumors. Therefore, an increased number of scientists have been shifting their research focus to explore the immunity regulation effects of anti-tumor traditional medicine or natural products. In this review, we summarize the research progress of traditional medicines on tumor immunity regulation in 2020. Our findings suggest that more herbal medicine-derived phytochemicals and formulas were derived from traditional Chinese medicine, and more papers were published in comprehensive journals. Traditional medicine can comprehensively regulate the tumor immune microenvironment, including natural killer cells, dendritic cells, CD4+/CD8+T lymphocytes, regulatory T cells, myeloid-derived suppressor cells, tumor-associated macrophages, immunosuppressive factors, and immune checkpoints. In 2020, a greater number of research papers focused on active ingredients and formulas that regulate tumor-associated macrophages and immune checkpoints. Active ingredients such as flavonoids became a global hotspot in 2020. Certain natural products were also found to exert synergistic anti-tumor activity with immune checkpoint inhibitors, such as curcumin. However, a distinct lack of high-quality experimental and clinical studies remains a prevalent and challenging issue that hinders the further development of traditional medicine.
Authors and Affiliations
Xue Yang, Xin-Yuan Luan
Keywords
Related Articles
- EP ID EP693637
- DOI 10.12032/TMR20210313223
- Views 126
- Downloads 0
Treating COVID-19 by traditional Chinese medicine: a charming strategy?
On April 14, 2020, the State Council of China announced that “three proprietary Chinese medicines and three decoctions” of effective traditional Chinese medicine (TCM) in the treatment of the novel coronavirus pneumonia...
Advances in traditional Chinese medicine for cardiovascular disease therapy in 2020
Cardiovascular diseases are a major cause of morbidity and mortality worldwide and there is an urgent need to develop new pharmacotherapies for managing cardiovascular diseases. In China, traditional Chinese medicine has...
Uncertainty profile for NIR analysis of tanshinone I content in tanshinone extract powders
A rapid, non-destructive and reliable NIR method was developed and validated for the quantification of tanshinone I content in Salvia miltiorrhiza extract. After spectral pretreatment, different variable selection method...
Massage for migraine: A meta-analysis
Objective:This systematic review examined whether massage interventions provided any measurable benefit in migraine disorders. Methods:Randomized controlled trials (RCTs) were searched for in Cochrane Library, PubMed, We...
Research on Xijiao Dihuang Decoction suppressing platelet apoptosis in immune-mediated aplastic anemia based on mitochondrial mediated pathway
The aplastic anemia mice model was established in this study. BALB/c mice shall be treated with whole body irradiation with 60 Co-γradiation (5.5Gy, 1.1Gy/min × 5 min). then within 4 h, DBA/2 mice were injected lymphocyt...